Setback for Organ Transplantion: First Human to Receive Pig Kidney Dies

▴ Setback for Organ Transplantion
While his story represents a significant step forward in medical innovation, it also highlights the complexities and risks associated with groundbreaking procedures.


In a recent medical development earlier this year, a man with end-stage renal disease received a genetically modified pig kidney in a transplant. The recipient, Rick Slayman, 62, tragically passed away recently, sparking interest and reflection on the potential of xenotransplantation in organ transplantation.

The Transplant and Its Significance: Mr. Rick Slayman underwent a four-hour surgery at Massachusetts General Hospital in March to receive a kidney from a genetically modified pig, marking a major milestone in medical science's quest to address the organ shortage crisis. This procedure aimed to provide more readily available organs to patients in need.

The hospital's transplant team expressed deep sadness at Mr. Slayman's passing but clarified that there was no indication that it was related to the recent transplant. The procedure utilized a kidney provided by eGenesis, a company based in Cambridge, Massachusetts, which specializes in genetic modification of pigs for organ transplantation.

Genetically Modified Pig Kidney: The pig kidney used in the transplant was specifically engineered to remove genes that could be harmful to a human recipient and incorporate certain human genes to enhance compatibility. Furthermore, eGenesis deactivated pig viruses that pose potential infection risks to humans, making the organ safer for transplantation.

Prior Successes and Research: Before human trials, eGenesis demonstrated the feasibility of pig organ transplantation by successfully transplanting kidneys from similarly modified pigs into monkeys. These animals survived for extended periods, with some living up to two years post-transplant.

The successful pig-to-monkey transplants lead the way for human trials, offering hope for individuals on organ transplant waiting lists. Researchers are optimistic about the potential of xenotransplantation to alleviate the shortage of viable donor organs.

Experimental Treatments and Immunosuppression: To prevent rejection of the pig kidney by Mr. Slayman's immune system, doctors utilized experimental immunosuppressive treatments, including an antibody called tegoprubart, developed by Eledon Pharmaceuticals. This approach aimed to enhance the organ's acceptance and prolong its function within the recipient's body.

Organ Shortage and Need for Innovation: The tragic passing of Mr. Slayman highlights the critical need for innovative approaches to address the growing demand for transplantable organs. In the United States alone, over 100,000 individuals await organ transplants, with kidneys being the most sought-after organs.

Ongoing Research and Future Prospects: Despite setbacks, the field of xenotransplantation continues to advance, with ongoing research exploring the potential of genetically modified animal organs as viable alternatives to human organs. Researchers and medical professionals remain committed to advancing this promising avenue to save lives and improve outcomes for patients awaiting transplants.

The passing of Rick Slayman is a poignant reminder of the challenges and opportunities in organ transplantation. While his story represents a significant step forward in medical innovation, it also highlights the complexities and risks associated with groundbreaking procedures.

As researchers continue to push the boundaries of medical science, the hope is that advancements in xenotransplantation will ultimately transform the landscape of organ transplantation, offering renewed hope to individuals awaiting life-saving treatments.

Tags : #

About the Author


Sunny Parayan

Hey there! I'm Sunny, a passionate writer with a strong interest in the healthcare domain! When I'm not typing on my keyboard, I watch shows and listen to music. I hope that through my work, I can make a positive impact on people's lives by helping them live happier and healthier.

View Profile

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Cancer in a Glass? What Science Says About Your Favourite WineMarch 27, 2025
BluHeat by Nysh.in Launches Innovative Cough Decongestion PatchesMarch 27, 2025
Jindal IVF plans to expand its presence in Himachal Pradesh and UPMarch 27, 2025
PartySmart Becomes India’s Go-To ‘Anti-Hangover Partner’ Across the Biggest Cultural FestivalsMarch 27, 2025
March 27, 2025
American Institute of Pathology & Laboratory Sciences (Ampath) in Collaboration Expands its Diagnostic Services in PunjabMarch 26, 2025
AI Prodigy at 14: The Boy Who Might Save Millions from Heart DiseaseMarch 26, 2025
Delhi Finally Joins Ayushman Bharat But Is It Too Late to Fix Its Healthcare Crisis?March 26, 2025
Why Epilepsy Awareness Day Should Matter to EveryoneMarch 26, 2025
Why Epilepsy Awareness Day Should Matter to EveryoneMarch 26, 2025
A $10 Million Bet on Life: How Everhope Oncology Plans to Fix India’s Cancer CareMarch 26, 2025
Honoring Changemakers: Lighthouse Canton Supports Rotary Club of Bombay’s Shakti Awards 2025 as Platinum SponsorMarch 26, 2025
Death in the Shadows: What’s Behind the Rising Child Fatalities in Jharkhand?March 26, 2025
The Future of Autism Therapy? Why Roper is Betting Big on CentralReachMarch 25, 2025
Scientists unveil world-leading technology to speed up drug discoveryMarch 25, 2025
Moscow Scientists Develop Questionnaire to Evaluate Doctors' Trust in AI Services: A Tool for International StudiesMarch 25, 2025
Indian MedTech Leader Remidio invests in UK’s Occuity to Enhance Non-Invasive Global Disease ScreeningMarch 25, 2025
HRV Global Life Sciences Strengthens Global Presence at DCAT Week 2025 in New YorkMarch 25, 2025
Ola Electric-Ola Electric Settles Rosmerta Dues, Insolvency Petitions WithdrawnMarch 25, 2025
6 Symptoms of Kidney Disease You Shouldn’t IgnoreMarch 25, 2025